Quick Answer
Hepion Pharmaceuticals, Inc. reported Total Assets of $3.07 million for the year ending 2025.
- Hepion Pharmaceuticals, Inc. showed an increase of +90.2% in Total Assets from 2024 to 2025.
- This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2013 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $76.0 thousand | Q4 2013: $8.8 thousand | Q1 2014: $2.64 million | Q3 2014: $1.00 million | Q4 2014: $8.96 million | Q1 2015: $9.50 million | Q3 2015: $2.85 million | Q4 2015: $10.65 million | Q1 2016: $6.75 million | Q3 2016: $8.82 million | Q4 2016: $16.07 million | Q1 2017: $11.76 million | Q2 2017: $18.38 million | Q3 2017: $14.12 million | Q1 2018: $9.40 million | Q2 2018: $7.98 million | Q3 2018: $14.38 million | Q1 2019: $7.90 million | Q2 2019: $23.34 million | Q3 2019: $21.07 million | Q1 2020: $23.27 million | Q2 2020: $24.08 million | Q3 2020: $20.36 million | Q1 2021: $123.76 million | Q2 2021: $119.75 million | Q3 2021: $111.60 million | Q1 2022: $95.86 million | Q2 2022: $83.57 million | Q3 2022: $69.70 million | Q1 2023: $49.50 million | Q2 2023: $36.50 million | Q3 2023: $25.00 million | Q1 2024: $15.99 million | Q2 2024: $6.01 million | Q3 2024: $3.72 million | Q1 2025: $6.32 million | Q2 2025: $4.51 million | Q3 2025: $3.74 million.
- Over the full 14 years of available data (2013 to 2025), Hepion Pharmaceuticals, Inc.'s Total Assets has grown by 3,440.2%.
- Historical annual values: Fiscal year 2025: $3.07 million | Fiscal year 2024: $1.61 million | Fiscal year 2023: $18.09 million | Fiscal year 2022: $60.24 million | Fiscal year 2021: $103.55 million | Fiscal year 2020: $48.65 million | Fiscal year 2019: $20.61 million | Fiscal year 2018: $8.19 million | Fiscal year 2017: $11.25 million | Fiscal year 2017: $18.38 million | Fiscal year 2016: $13.11 million | Fiscal year 2015: $5.38 million | Fiscal year 2014: $2.00 million | Fiscal year 2013: $86.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: